This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Walgreens (WBA) Inks Deal to Expand COVID-19 Testing Access
by Zacks Equity Research
Walgreens' (WBA) recent deal with Abbott is part of its ongoing efforts to offer greater testing access, helping reduce the spread of COVID-19 and improve the health of communities.
Walgreens (WBA) Extends COVID-19 Vaccination to 49 States
by Zacks Equity Research
Walgreens (WBA) continues to expand access to COVID-19 vaccination in medically underserved communities and has surpassed 11 million administrations to date.
Company News for Apr 1, 2021
by Zacks Equity Research
Companies in The News Are: WBA,AYI,UNF,CHWY
Walgreens Boots (WBA) Q2 Earnings Top Estimates, Margins Down
by Zacks Equity Research
Walgreens Boots' (WBA) fiscal second-quarter results reflect overall top-line improvement despite COVID-19-led business disruptions.
Walgreens Boots Alliance (WBA) Beats Q2 Earnings Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 27.27% and -3.15%, respectively, for the quarter ended February 2021. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Walgreen Boots (WBA)
by Zacks Equity Research
Walgreen Boots (WBA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why Walgreens (WBA) Could Beat Earnings Estimates Again
by Zacks Equity Research
Walgreens (WBA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
FedEx, NIKE, Costco Wholesale, Micron Technology, Walgreens Boots Alliance, McCormick & Co, Lululemon and JPMorgan are part of Zacks Earnings Preview
by Zacks Equity Research
FedEx, NIKE, Costco Wholesale, Micron Technology, Walgreens Boots Alliance, McCormick & Co, Lululemon and JPMorgan are part of Zacks Earnings Preview
A Very Strong Q1 and 2021 Earnings Picture
by Sheraz Mian
This improving trend in estimate revisions accelerated over the last few months, as the chart below highlighting the evolution of 2021 Q1 earnings growth estimates shows...
Earnings Preview: Walgreens Boots Alliance (WBA) Q2 Earnings Expected to Decline
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Walgreens Boots' (WBA) Retail Arm be Dull in Q2 Earnings?
by Zacks Equity Research
Walgreens Boots' (WBA) Retail Pharmacy International sales are likely to have remained dull in Q2 on difficult global market scenario.
Stock Market News for Mar 16, 2021
by Zacks Equity Research
Benchmarks closed modestly higher on Monday as investors continued to show optimism about economic recovery
Stock Market News for Mar 15, 2021
by Zacks Equity Research
The Dow and the S&P 500 closed at record highs on Friday as investors poured money into cyclical stocks poised to benefit from the economic recovery this year.
5 Hottest Stocks in the Dow ETF
by Sweta Killa
Dow Jones has been hitting new record highs lately on an expected economic surge as cyclical sectors are outperforming after being beaten down badly amid the coronavirus crisis.
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife, Rite Aid and Amazon
by Zacks Equity Research
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife, Rite Aid and Amazon
3 Pharmacies & Drugstore Stocks to Watch Amid COVID-19 Resurgence
by Urmimala Biswas
Despite severe COVID-19 challenges, higher demand for telemedicine and federal collaborations for vaccine rollout are likely to lend support to the Zacks Retail - Pharmacies and Drug Stores industry. HLF is well positioned to gain now while CVS and RAD hold huge prospects.
Zacks Market Edge Highlights: Walgreens Boots, Johnson & Johnson, Chipotle, Lululemon and XLK
by Zacks Equity Research
Zacks Market Edge Highlights: Walgreens Boots, Johnson & Johnson, Chipotle, Lululemon and XLK
How to Create a Stock Portfolio
by Tracey Ryniec
You want to buy stocks. But how do you create a portfolio?
The Zacks Analyst Blog Highlights: Mastercard, Lowe's, Uber, Ericsson and Walgreens Boots Alliance
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Mastercard, Lowe's, Uber, Ericsson and Walgreens Boots Alliance
Q4 Earnings Season Scorecard and Analyst Reports for Mastercard, Lowe's & Uber
by Sheraz Mian
We have provided a real-time update on the Q4 earnings season, in addition to featuring new research reports on 16 major stocks in today's Research Daily.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $50.38, marking a +0.52% move from the previous day.
Walgreens (WBA) and UBER Tie Up to Expand COVID Vaccine Access
by Zacks Equity Research
Walgreens (WBA) and UBER to provide up to 10 million free or discounted rides to underserved communities.
Why Is Walgreens (WBA) Up 10.1% Since Last Earnings Report?
by Zacks Equity Research
Walgreens (WBA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $49.81 in the latest trading session, marking a +1.1% move from the prior day.
Microsoft (MSFT) Q2 Earnings Beat, Azure & Gaming Aid Top Line
by Zacks Equity Research
Microsoft's (MSFT) fiscal second-quarter results benefit from momentum in Azure, impressive Teams user growth led by work-from-home wave and solid uptake of new Xbox consoles.